AURA SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AURA SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $50.0K | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $56.0K | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $71.0K | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $100.0K | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $114.9K | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $822.0K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $39.3K | Jul 13, 2020 |
| FY2017 | Feb 29, 2016 | $183.0K | Sep 18, 2017 |
| FY2016 | Feb 28, 2015 | $1.16M | Sep 18, 2017 |
| FY2015 | Feb 28, 2014 | $2.32M | Sep 18, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $21.0K | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($137.0K) | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | ($17.0K) | May 26, 2023 |
| FY2023 | Feb 28, 2022 | ($24.0K) | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $33.5K | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $644.9K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($131.0K) | Jul 13, 2020 |
| FY2017 | Feb 28, 2017 | $0 | Sep 18, 2017 |
| FY2017 | Feb 29, 2016 | $12.0K | Sep 18, 2017 |
| FY2016 | Feb 28, 2015 | $665.4K | Sep 18, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($21.14M) | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($4.22M) | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | ($3.41M) | May 26, 2023 |
| FY2023 | Feb 28, 2022 | ($3.99M) | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $44.7K | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | ($2.61M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($2.50M) | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $1.70M | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | ($7.73M) | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | ($6.60M) | Sep 18, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($4.81M) | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($2.76M) | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | ($3.50M) | May 26, 2023 |
| FY2023 | Feb 28, 2022 | ($3.43M) | May 26, 2023 |
| FY2022 | Feb 28, 2021 | ($1.78M) | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | ($1.04M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($4.22M) | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | ($5.91M) | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | ($3.56M) | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | ($3.37M) | Sep 18, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.25M | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $750.0K | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $850.0K | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $611.0K | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $237.5K | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $172.4K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $494.6K | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $102.7K | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | $34.2K | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | $395.7K | Sep 18, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $3.59M | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $1.87M | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $2.64M | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $2.80M | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $1.58M | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $1.26M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $3.59M | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $5.80M | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | $3.52M | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | $2.98M | Sep 18, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($3.22M) | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($3.00M) | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | ($3.12M) | May 26, 2023 |
| FY2023 | Feb 28, 2022 | ($2.64M) | May 26, 2023 |
| FY2022 | Feb 28, 2021 | ($1.89M) | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | ($793.8K) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($2.46M) | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | ($2.81M) | Oct 24, 2019 |
| FY2014 | Feb 28, 2014 | ($5.86M) | Jun 13, 2014 |
| FY2014 | Feb 28, 2013 | ($6.16M) | Jun 13, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $103.0K | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $22.0K | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $54.0K | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $196.0K | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $15.6K | Jun 21, 2022 |
| FY2014 | Feb 28, 2014 | $0 | Jun 13, 2014 |
| FY2014 | Feb 28, 2013 | $0 | Jun 13, 2014 |
| FY2012 | Feb 29, 2012 | $0 | Jun 12, 2013 |
| FY2011 | Feb 28, 2011 | $9.6K | May 29, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.48M | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $1.46M | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $1.75M | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $2.20M | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $1.94M | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $111.3K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $668.1K | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $1.04M | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | $262.3K | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | $130.8K | Sep 18, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $39.07M | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $22.98M | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $22.01M | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $23.41M | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $23.06M | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $23.41M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $22.26M | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $25.71M | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | $53.07M | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | $45.30M | Sep 18, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($37.59M) | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($21.52M) | Jun 13, 2025 |
| FY2025 | Feb 28, 2023 | ($20.26M) | Jun 13, 2025 |
| FY2023 | Feb 28, 2022 | ($21.22M) | May 26, 2023 |
| FY2023 | Feb 28, 2021 | ($21.12M) | May 26, 2023 |
| FY2022 | Feb 29, 2020 | ($23.86M) | Jun 21, 2022 |
| FY2021 | Feb 28, 2019 | ($21.59M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2018 | ($24.67M) | Jul 13, 2020 |
| FY2019 | Feb 28, 2017 | ($52.81M) | Oct 24, 2019 |
| FY2018 | Feb 29, 2016 | ($45.17M) | Jun 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($500.13M) | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | ($478.99M) | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | ($474.77M) | May 26, 2023 |
| FY2023 | Feb 28, 2022 | ($471.36M) | May 26, 2023 |
| FY2022 | Feb 28, 2021 | ($467.37M) | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | ($466.73M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($464.12M) | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | ($461.62M) | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | ($463.32M) | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | ($455.59M) | Sep 18, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $23.0K | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | $124.0K | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | $15.0K | May 26, 2023 |
| FY2023 | Feb 28, 2022 | $150.0K | May 26, 2023 |
| FY2022 | Feb 28, 2021 | $390.7K | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | $19.8K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $358.2K | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | $748.0K | Oct 24, 2019 |
| FY2019 | Feb 28, 2017 | $255.9K | Jun 13, 2019 |
| FY2018 | Feb 29, 2016 | $22.2K | Jun 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Feb 29, 2016 | $1.37M | Sep 18, 2017 |
| FY2015 | Feb 28, 2015 | $1.28M | Sep 18, 2017 |
| FY2014 | Feb 28, 2014 | $1.19M | Jun 13, 2014 |
| FY2012 | Feb 28, 2013 | $1.45M | Jun 12, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | 0 | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | 0 | May 26, 2023 |
| FY2023 | Feb 28, 2022 | 0 | May 26, 2023 |
| FY2022 | Feb 28, 2021 | 0 | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | 0 | Jun 1, 2021 |
| FY2019 | Feb 28, 2019 | 0 | Oct 24, 2019 |
| FY2019 | Feb 28, 2018 | 0 | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | 0 | Jun 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | 0 | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | 0 | May 26, 2023 |
| FY2023 | Feb 28, 2022 | 0 | May 26, 2023 |
| FY2022 | Feb 28, 2021 | 0 | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | 0 | Jun 1, 2021 |
| FY2019 | Feb 28, 2019 | 0 | Oct 24, 2019 |
| FY2019 | Feb 28, 2018 | 0 | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | 0 | Jun 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 118.30M | Jun 13, 2025 |
| FY2025 | Feb 29, 2024 | 104.59M | Jun 13, 2025 |
| FY2023 | Feb 28, 2023 | 94.65M | May 26, 2023 |
| FY2023 | Feb 28, 2022 | 83.12M | May 26, 2023 |
| FY2022 | Feb 28, 2021 | 71.10M | Jun 21, 2022 |
| FY2021 | Feb 29, 2020 | 56.40M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | 53.71M | Jul 13, 2020 |
| FY2019 | Feb 28, 2018 | 41.44M | Oct 24, 2019 |
| FY2018 | Feb 28, 2017 | 16.28M | Jun 13, 2018 |
| FY2017 | Feb 29, 2016 | 113.04M | Sep 18, 2017 |